Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2021

01-06-2021 | COVID-19 | Original Article

Endoscopic Retrograde Cholangiopancreatography During the COVID-19 Pandemic: Effects of Enhanced Personal Protective Equipment

Authors: Tolga Düzenli, Hüseyin Köseoğlu

Published in: Digestive Diseases and Sciences | Issue 6/2021

Login to get access

Abstract

Background and Aims

Personal protective equipment (PPE) decreases the risk of disease contagion, and because of the COVID-19 pandemic, enhanced PPE (EPPE) is widely used during endoscopic procedures including endoscopic retrograde cholangiopancreatography (ERCP). The aim of this study was to investigate the effects of EPPE on ERCP success parameters compared to standard PPE (SPPE).

Methods

ERCP procedures were evaluated retrospectively and ERCP outcomes were compared for similar time periods as before and after the COVID-19 pandemic. Primary outcomes were cannulation time, number of cannulation attempts, cannulation success rate, difficult cannulation rate, undesired pancreatic duct cannulation rate, ERCP-related adverse events, and length of hospital stay.

Results

Three hundred and eighty ERCP procedures were examined. One hundred and fifty-nine procedures were excluded due to missing data, previous sphincterotomy or altered anatomy. Of the final eligible sample size of 221 ERCPs, 93 were performed using SPPE and 128 were performed under EPPE. Indications of ERCP and demographic parameters were similar between groups. The majority of the ERCP cases included were for benign biliary obstruction of common bile duct stones (88.7%). No significant differences were detected in overall technical success (91.4% vs 92.2%, p = 0.832), cannulation success rates (94.6% vs 96.8%, p = 0.403), cannulation times (median times of both groups were 3 min, p = 0.824), difficult cannulation rates (37.6% vs 33.6%, p = 0.523), undesired pancreatic duct cannulation rates (29% vs 22.7%, p = 0.593), number of cannulation attempts (2.80 vs 2.71, p = 0.731), ERCP-related adverse events (9.7% vs 10.9%, p = 0.762), and length of hospital stay (6.63 vs 6.92 days, p = 0.768) between SPPE and EPPE groups, respectively.

Conclusion

Biliary obstructions of common bile duct stones were the major indication of ERCP in the current study. The use of EPPE had no negative effects on ERCP performance in this patient group. ERCP can be effectively performed under EPPE.
Literature
1.
go back to reference Repici A, Maselli R, Colombo M et al. Coronavirus (COVID-19) outbreak: what the department of endoscopy should know. Gastrointest Endosc 2020;92:192–197CrossRef Repici A, Maselli R, Colombo M et al. Coronavirus (COVID-19) outbreak: what the department of endoscopy should know. Gastrointest Endosc 2020;92:192–197CrossRef
2.
go back to reference Castro Filho EC, Castro R, Fernandes FF et al. Gastrointestinal endoscopy during the COVID-19 pandemic: an updated review of guidelines and statements from international and national societies. Gastrointest Endosc 2020;92:440-445.e6CrossRef Castro Filho EC, Castro R, Fernandes FF et al. Gastrointestinal endoscopy during the COVID-19 pandemic: an updated review of guidelines and statements from international and national societies. Gastrointest Endosc 2020;92:440-445.e6CrossRef
3.
go back to reference Wong SH, Lui RN, Sung JJ. Covid-19 and the digestive system. J Gastroenterol Hepatol 2020;35:744–748CrossRef Wong SH, Lui RN, Sung JJ. Covid-19 and the digestive system. J Gastroenterol Hepatol 2020;35:744–748CrossRef
4.
go back to reference Wilson NM, Norton A, Young FP et al. Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review. Anaesthesia 2020;75:1086–1095CrossRef Wilson NM, Norton A, Young FP et al. Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review. Anaesthesia 2020;75:1086–1095CrossRef
5.
go back to reference Johnson AT. Respirator masks protect health but impact performance: a review. J Biol Eng 2016;10:4CrossRef Johnson AT. Respirator masks protect health but impact performance: a review. J Biol Eng 2016;10:4CrossRef
6.
go back to reference Palmiero AJ, Symons D, Morgan JW et al. Speech intelligibility assessment of protective facemasks and air-purifying respirators. J Occup Environ Hyg 2016;13:960–968CrossRef Palmiero AJ, Symons D, Morgan JW et al. Speech intelligibility assessment of protective facemasks and air-purifying respirators. J Occup Environ Hyg 2016;13:960–968CrossRef
7.
go back to reference Roberge RJ. Face shields for infection control: a review. J Occup Environ Hyg 2016;13:235–242CrossRef Roberge RJ. Face shields for infection control: a review. J Occup Environ Hyg 2016;13:235–242CrossRef
8.
go back to reference Dumonceau JM, Kapral C, Aabakken L et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2020;52:127–149CrossRef Dumonceau JM, Kapral C, Aabakken L et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2020;52:127–149CrossRef
9.
go back to reference An P, Huang X, Wan X et al. ERCP during the pandemic of COVID-19 in Wuhan. China. Gastrointest Endosc 2020;92:448–454CrossRef An P, Huang X, Wan X et al. ERCP during the pandemic of COVID-19 in Wuhan. China. Gastrointest Endosc 2020;92:448–454CrossRef
10.
go back to reference Teh KKJ, Tay SW, Chen K et al. Impact of enhanced personal protective equipment on colonoscopy performance during the COVID-19 pandemic. Endosc Int Open 2020;8:E809–E814CrossRef Teh KKJ, Tay SW, Chen K et al. Impact of enhanced personal protective equipment on colonoscopy performance during the COVID-19 pandemic. Endosc Int Open 2020;8:E809–E814CrossRef
14.
go back to reference Mahadev S, Aroniadis OC, Barraza LH et al. Gastrointestinal endoscopy during the coronavirus pandemic in the New York area: results from a multi-institutional survey. Endosc Int Open 2020;8:E1865–E1871CrossRef Mahadev S, Aroniadis OC, Barraza LH et al. Gastrointestinal endoscopy during the coronavirus pandemic in the New York area: results from a multi-institutional survey. Endosc Int Open 2020;8:E1865–E1871CrossRef
15.
go back to reference Lantinga MA, Theunissen F, Ter Borg PCJ et al. Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database. Endoscopy 2020;53:166–170CrossRef Lantinga MA, Theunissen F, Ter Borg PCJ et al. Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database. Endoscopy 2020;53:166–170CrossRef
16.
go back to reference Salerno R, Conti CB, De Silvestri A et al. The impact of covid-19 pandemic on urgent endoscopy in Italy: a nation-wide multicenter study. Scand J Gastroenterol 2020;55:870–876CrossRef Salerno R, Conti CB, De Silvestri A et al. The impact of covid-19 pandemic on urgent endoscopy in Italy: a nation-wide multicenter study. Scand J Gastroenterol 2020;55:870–876CrossRef
17.
go back to reference O’Grady J, Leyden J, MacMathuna P et al. ERCP and SARS-COV-2: an urgent procedure that should be immune. Scand J Gastroenterol 2020;55:976–978CrossRef O’Grady J, Leyden J, MacMathuna P et al. ERCP and SARS-COV-2: an urgent procedure that should be immune. Scand J Gastroenterol 2020;55:976–978CrossRef
19.
go back to reference Voiosu T, Voiosu A, Boškoski I et al. Technical and clinical outcomes of endoscopic retrograde cholangiopancreatography (ERCP) procedures performed in patients with COVID-19. Therap Adv Gastroenterol 2020;13:1756284820980671CrossRef Voiosu T, Voiosu A, Boškoski I et al. Technical and clinical outcomes of endoscopic retrograde cholangiopancreatography (ERCP) procedures performed in patients with COVID-19. Therap Adv Gastroenterol 2020;13:1756284820980671CrossRef
Metadata
Title
Endoscopic Retrograde Cholangiopancreatography During the COVID-19 Pandemic: Effects of Enhanced Personal Protective Equipment
Authors
Tolga Düzenli
Hüseyin Köseoğlu
Publication date
01-06-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2021
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-06940-4

Other articles of this Issue 6/2021

Digestive Diseases and Sciences 6/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.